BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND EPAS1, MOP2, 2034, ENSG00000116016, PASD2, HIF2A, Q99814 AND Treatment
22 results:

  • 1. Radiological imaging protection: a study on imaging dose used while planning computed tomography for external radiotherapy in Japan.
    Kito S; Suda Y; Tanabe S; Takizawa T; Nagahata T; Tohyama N; Okamoto H; Kodama T; Fujita Y; Miyashita H; Shinoda K; Kurooka M; Shimizu H; Ohno T; Sakamoto M
    J Radiat Res; 2024 Mar; 65(2):159-167. PubMed ID: 38151953
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical Features and Prognoses of Patients With breast cancer Who Underwent Surgery.
    Liu G; Kong X; Dai Q; Cheng H; Wang J; Gao J; Wang Y
    JAMA Netw Open; 2023 Aug; 6(8):e2331078. PubMed ID: 37624596
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Precision oncology options in urological cancers].
    Franz A; Plage H; Fendler A; Schlomm T; Kornienko K
    Urologie; 2023 Jul; 62(7):696-704. PubMed ID: 37294331
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ZnO Nanorods Create a Hypoxic State with Induction of HIF-1 and epas1, Autophagy, and Mitophagy in cancer and Non-cancer Cells.
    Aventaggiato M; Preziosi A; Cheraghi Bidsorkhi H; Schifano E; Vespa S; Mardente S; Zicari A; Uccelletti D; Mancini P; Lotti LV; Sarto MS; Tafani M
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108134
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
    Shirvaliloo M
    Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.
    Roberts KE; Adsett IT; Rickett K; Conroy SM; Chatfield MD; Woodward NE
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013167. PubMed ID: 35005781
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Biopsychosocial risk factors and knowledge of cervical cancer among young women: A case study from Kenya to inform HPV prevention in Sub-Saharan Africa.
    Ngune I; Kalembo F; Loessl B; Kivuti-Bitok LW
    PLoS One; 2020; 15(8):e0237745. PubMed ID: 32817627
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of genes and pathways related to lymphovascular invasion in breast cancer patients: A bioinformatics analysis of gene expression profiles.
    Klahan S; Wong HS; Tu SH; Chou WH; Zhang YF; Ho TF; Liu CY; Yih SY; Lu HF; Chen SC; Huang CC; Chang WC
    Tumour Biol; 2017 Jun; 39(6):1010428317705573. PubMed ID: 28651487
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Estrogen-dependent downregulation of hypoxia-inducible factor (HIF)-2α in invasive breast cancer cells.
    Fuady JH; Gutsche K; Santambrogio S; Varga Z; Hoogewijs D; Wenger RH
    Oncotarget; 2016 May; 7(21):31153-65. PubMed ID: 27105516
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mutation Yield of a 34-Gene Solid Tumor Panel in Community-Based Tumor Samples.
    Sanders H; Qu K; Li H; Ma L; Barlan C; Zhang X; Prentice J; Wolfson D; Crossley B; Sferruzza A; Sninsky J; Ross D; Grupe A; Catanese J; Hantash F; Waldman F
    Mol Diagn Ther; 2016 Jun; 20(3):241-53. PubMed ID: 27084556
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy.
    de Haas S; Delmar P; Bansal AT; Moisse M; Miles DW; Leighl N; Escudier B; Van Cutsem E; Carmeliet P; Scherer SJ; Pallaud C; Lambrechts D
    Angiogenesis; 2014 Oct; 17(4):909-20. PubMed ID: 25012543
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genotyping analysis and ¹⁸FDG uptake in breast cancer patients: a preliminary research.
    Bravatà V; Stefano A; Cammarata FP; Minafra L; Russo G; Nicolosi S; Pulizzi S; Gelfi C; Gilardi MC; Messa C
    J Exp Clin Cancer Res; 2013 Apr; 32(1):23. PubMed ID: 23631762
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Male breast cancer: management and follow-up recommendations.
    Kiluk JV; Lee MC; Park CK; Meade T; Minton S; Harris E; Kim J; Laronga C
    Breast J; 2011; 17(5):503-9. PubMed ID: 21883641
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A gene expression signature identifies two prognostic subgroups of basal breast cancer.
    Sabatier R; Finetti P; Cervera N; Lambaudie E; Esterni B; Mamessier E; Tallet A; Chabannon C; Extra JM; Jacquemier J; Viens P; Birnbaum D; Bertucci F
    Breast Cancer Res Treat; 2011 Apr; 126(2):407-20. PubMed ID: 20490655
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. breast-conserving surgery in 201 very young patients (<35 years).
    Gentilini O; Botteri E; Rotmensz N; Toesca A; De Oliveira H; Sangalli C; Colleoni M; Intra M; Galimberti V; Veronesi P; Luini A; Veronesi U
    Breast; 2010 Feb; 19(1):55-8. PubMed ID: 19944605
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. breast cancer in young women: poor survival despite intensive treatment.
    Fredholm H; Eaker S; Frisell J; Holmberg L; Fredriksson I; Lindman H
    PLoS One; 2009 Nov; 4(11):e7695. PubMed ID: 19907646
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. breast cancer in young women and its impact on reproductive function.
    Hickey M; Peate M; Saunders CM; Friedlander M
    Hum Reprod Update; 2009; 15(3):323-39. PubMed ID: 19174449
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The determinants of traditional Chinese medicine and acupuncture utilization for cancer patients with simultaneous conventional treatment.
    Pu CY; Lan VM; Lan CF; Lang HC
    Eur J Cancer Care (Engl); 2008 Jul; 17(4):340-9. PubMed ID: 18537814
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The burden of adult obesity in Canada.
    Luo W; Morrison H; de Groh M; Waters C; DesMeules M; Jones-McLean E; Ugnat AM; Desjardins S; Lim M; Mao Y
    Chronic Dis Can; 2007; 27(4):135-44. PubMed ID: 17623559
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
    Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.